And comparison of COVID-19 VTE and historical ICU co-horts. Thrombosis in COVID higher in well matched ARDS patients and also higher than in patients with flu. @accpchest #CHEST2020 #CHESTCritCare 
Risk factors for the development of thrombosis are essentially the same, but COVID patients are staying hospitalized longer. #CHEST2020 #CHESTCritCare
Some patients are presenting with DVT and arterial clots related to COVID, but without respiratory symptoms. These patients should probably be tested for Sars-CoV-2
Impaired fibrinolysis and increased clot strength with higher megacariocytes in the lunch compared to non-COVID ARDS seems to be associated with the pathophys. #CHEST2020 #CHESTCritCare @accpchest
Is it DIC? Likely not, excellent graph below showing differences in platelet coins and fibrinogen levels in patients with and without COVID-19. @accpchest #CHEST2020 #CHESTCritCare
The available data is conflicting in regards to recommending full anticoagulation versus higher dose prophylaxis, for now, these are the guidelines @accpchest #CHEST2020 #CHESTCritCare
Special considerations should be made when choosing the appropriate medication for anticoagulation/VTE prophylaxis @accpchest #CHESTCritCare #CHEST2020
• • •
Missing some Tweet in this thread? You can try to
force a refresh
